Erythropoietin use and immunogenicity of hepatitis B virus vaccine in chronic kidney disease patients: A meta-analysis

Kidney and Blood Pressure Research

Volumn 35, Issue 6, 2013, Pages 504-510

  Fabrizi, Fabrizio ^a,b   Dixit, Vivek ^b   Martin, Paul ^b   Messa, Piergiorgio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Dialysis; Hepatitis B virus; Meta analysis; Recombinant human erythropoietin; Vaccine

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT ERYTHROPOIETIN;

ANTIBODY TITER; ARTICLE; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

ERYTHROPOIETIN; HEPATITIS B VACCINES; HUMANS; IMMUNOGENETIC PHENOMENA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84863858116     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000335956     Document Type: Article

References (40)

1. Fabrizi F, Martin P: Hepatitis B virus infection in dialysis patients. Am J Nephrol 2000; 20: 1-11.
2. Centers for Disease Control and Prevention: Recommendations for preventing transmission of infections among chronic haemodialysis patients. MMWR 2001; 50: 1-43.
3. Jibani MM, Heptonstall J, Walker AM, Bloodworth LO, Howard AJ: Hepatitis B immunization in UK renal units: Failure to put policy into practice. Nephrol Dial Transplant 1994; 9: 1765-1768.
4. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ: National surveillance of dialysisassociated diseases in the United States, 2002. Semin Dial 2005; 18: 52-61.
5. Kruger S, Muller-Steinhardt M, Kirchner H, et al: A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients. Am J Kidney Dis 2001; 38: 1264-1271.
6. Poynard T, Conn HO: The retrieval of randomised clinical trials in liver diseases from the medical literature: A comparison of Medlars and manual methods. Control Clin Trials 1985; 6: 271-279.
7. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
8. Petitti DB: Approaches to heterogeneity in meta-analysis. Statist Med 2001; 20: 3625-3633.
9. Higgins JPT, Thompson SG, Deeks JI, Altman DG: Measuring inconsistencies in meta-analysis. Br Med J 2003; 327: 557-560.
10. Galbraith RF: A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988; 7: 889-894.
11. Klein S, Simes J, Blackburn GL: Total parenteral nutrition and cancer clinical trial. Cancer 1986; 58: 1378-1386.
12. Sennesael J, van Der Niepen P, Verbeelen D: Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int 1991; 40: 121-128.
13. Lombardi M, Pizzarelli F, Righi M, Cerrai P, Dattolo P, Nigrelli S, Michelassi S, Sisca S, Alecci A, Di Geronimo P, Maggiore Q: Hepatitis B vaccination in dialysis patients and nutritional status. Nephron 1992; 61: 266-268.
14. Khan A, Bernardini J, Rault R, Piraino B: Low seroconversion with hepatitis B vaccination in peritoneal dialysis patients. Perit Dial Int 1996; 16: 370-373.
15. Navarro J, Teruel J, Mateos M, Marcen R, Ortuno J: Antibody level after hepatitis B vaccination in hemodialysis patients: Influence of hepatitis C virus infection. Am J Nephrol 1996; 16: 95-97.
16. Peces R, de la Torre M, Alcazar R, Urra JM: Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis 1997; 29: 239-245.
17. Anandh U, Thomas P, Shastry J, Jacob CK: A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin. J Assoc Physicians India 2000; 48: 1061-1063.
18. Hassan K, Shternberg L, Alhaj M, Giron R, Reshef R, Barak M, Kristal B: The effect of erythropoietin therapy and hemoglobin levels on the immune response to Engerix-B vaccination in chronic kidney disease. Ren Fail 2003; 25: 471-478.
19. DaRoza G, Loewen A, Djurdjev O, Loce J, Kempston C, Burnett S, Klaii M, Taylor P, Levin A: Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: Earlier is better. Am J Kidney Dis 2003; 42: 1184-1192.
20. Kara I, Yilmaz M, Suner A, Kadiroglu A, Isikoglu B: The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Vaccine 2004; 22: 3963-3967.
21. Chow K, Law M, Leung C, Szeto C, Li P: Antibody response to hepatitis B vaccine in endstage renal disease patients. Nephron Clin Pract 2006; 103:c89-c93.
22. Afsar B, Elsurer R, Eyileten T, Yilmaz M, Caglar K: Antibody response following hepatitis B vaccination in dialysis patients: Does depression and life quality matter? Vaccine 2009; 27: 5865-5869.
23. Girndt M, Kohler H: Hepatitis B virus infection in hemodialysis patients. Semin Nephrol 2002; 22: 340-350.
24. Pesanti EL: Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 2001; 15: 813-821.
25. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G: Meta-analysis: The effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther 2004; 20: 1053-1062.
26. Fernandez E, Betru MA, Gomez R, Montoliu J: Response to the hepatitis B virus vaccine in haemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 1996; 11: 1559-1563.
27. Ahuja TS, Kumar S, Mansoury H, Rodriguez H, Kuo YF: Hepatitis B vaccination in human immunodeficiency virus-infected adults receiving haemodialysis. Kidney Int 2005; 67: 1136-1141.
28. Pol S, Legendre C, Mattlinger B, Berthelot P, Krein H: Genetic basis of nonresponse to hepatitis B vaccine in hemodialysis patients. J Hepatol 1990; 11: 385-387.
29. Alavian SM, Tabatabaei S: The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of clinical trials. Vaccine 2010; 28: 3773-3777.
30. Kimata H, Yoshida A, Ishioka C, Masuda S, Sasaki R, Mikana H: Human recombinant erythropoietin directly stimulates B cell immunoglobulin production and proliferation in serum free medium. Exp Immunol 1991; 85: 151-156.
31. Huraib S, Abu Aisha H, Al Momen A, Al Wakeel J, Memon N, Al Tuwaijri A: Effect of recombinant human erythropoietin on lymphocyte phenotyping and phagocyte activity in hemodialysis patients. Am J Kidney Dis 1997; 29: 866-870.
32. Shurtz Swirski R, Kristal B, Shkolnik T, Weissman I, Shapiro G, Shasha SM: Shortterm effect of erythropoietin on T-cell mitogenic proliferation in chronic renal failure patients. Nephron 1996; 72: 27-29.
33. Eardley K, Jones H, Osman H, Smith S: Efficacy of the accelerated hepatitis B vaccination schedule used in haemodialysis patients post-exposure to virus: A single-centre experience. Nephrol Dial Trasplant 2002; 17: 1982-1987.
34. Kovacic V, Sain M, Vukman V: Efficient haemodialysis improves the response to hepatitis B virus vaccination. Intervirology 2002; 45: 172-176.
35. Fabrizi F, Di Filippo S, Marcelli D, Guarnori I, Raffaele L, Crepaldi M, Erba G, Locatelli F: Recombinant hepatitis B vaccine use in chronic hemodialysis patients. Nephron 1996; 72: 536-543.
36. Liu J, Liu Y, Lin H, Yang Y, Kuo H, Lin P, Huang C: Intravenous iron attenuates postvaccination anti-HBsAg titers after quadruple hepatitis B vaccination in dialysis patients with erythopoietin therapy. Int J Clin Pract 2009; 63: 387-393.
37. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP: Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-613.
38. Waite M, Thomson L, Goldstein M: Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine. J Am Soc Nephrol 1995; 5: 1930-1934.
39. Marangi A, Giordano R, Montanaro A, De Padova F, Schiavone MG, Dongiovanni G, Basile C: Hepatitis B virus infection in chronic uremia: Long-term follow-up of a two-step integrated protocol of vaccination. Am J Kidney Dis 1994; 23: 537-542.
40. Rangel M, Coronado V, Euler G, Strikas R, for the Advisory Committee on Immunization Practices and the American Academy of Pediatrics: Vaccine recommendations for patients on chronic dialysis. Semin Dial 2002; 13: 101-107.